Skip to main content

Positron Emission Tomography and Boron Neutron Capture Therapy System to the Patient with Malignant Brain Tumor

The First Clinical Trial Using10B-BPA

  • Chapter
Cancer Neutron Capture Therapy

Abstract

We have conjugated a positron tracer F-18 to [10B]boronophenylalanine (10B-BPA) to synthesize [18F]fluoroboronophenylalanine (18F-10B-DL-BPA or 18F-10B-L-BPA), and analyzed 1013-BPA metabolism on 27 cases of the various brain tumors by positron emission tomography (PET). These PET data revealed that 18F-10B-BPA using the DL-form was actively incorporated to the malignant tumor cells, showing high B-10 concentration and T/N ratio, which was suggested of the sufficient effectiveness of boron neutron capture therapy (BNCT) on the malignant brain tumor. The experimental studies were undertaken with rat glioma model which showed that BNCT using 10B-L-BPA brought the good antitumor effect on rat glioma and no side effect on normal brain. Under this PET-BNCT system, the patient with malignant brain tumor was treated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H.Hatanaka, K.Sano and H.Yasukochi, Clinical results of boron neutron capture therapy, in: Progress in Neutron Capture Therapy for Cancer, B.J.Allen et al,ed.. Plenum, New York, 1992, 561–568.

    Chapter  Google Scholar 

  2. Y.Nakagawa, S.Ogura, K.Kitamura, T.Kageji, T.Gyoten, H.Hatanaka, F.Tsuji, K.Mukai, K.Matsumoto. T.Kobayashi and K.Kanda, Boron neutron capture therapy-Clinical study-. KURRI, Prog.Rep., Osaka, 1992, 318–3 19.

    Google Scholar 

  3. Y.Oda, M.Takagaki and H.Kikuchi. Clinical experiences of BNCT on glioblasoma, KURRI Prog.Rep., Osaka, 1992, 308–309.

    Google Scholar 

  4. Y.Mishima, C.Honda, M.Ichihashi, H.Obara, J.Hiratsuka, H.Fukuda, H.Karashima, T.Kobayashi, K.Kanda and K.Yoshino, Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 1°B-compound. Lancet 11, 388–389, 1989.

    Article  Google Scholar 

  5. Y.Mishima, M.Ichihashi, C.Honda, M.Shiono, T,Nakagawa, H.Obara, J.Shirakawa, J.Hiratsuka, K.Kanda, T.Kobayashi, T.Nozaki, O.Aizawa, T.Sato, H.Karashima, K.Yoshino and H.Fukuda, Advances in the control of human cutaneous primary and metastatic melanoma by thermal neutron capture therapy, in:Progress in Neutron Capture Therapy for Cancer, B.J.Allen et al, ed., Plenum, New York, 1992, 577–583.

    Chapter  Google Scholar 

  6. K.Ishiwata, T.Ido, M.Kawamura, K.Kubota, M.Ichihashi and Y.Mishima, 4-borono-2-[’8F]fluoro-D-Lphenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Nucl.Med.Bio1. 18: 745–751, 1991.

    CAS  Google Scholar 

  7. S.Ueda and Y.Imahori, PET-BNCT System for Malignant Brain Tumor, J.Therap.(Jpn). 74: 1314 1315, 1992.

    Google Scholar 

  8. YImahori, S.Ueda, Y.Ohmori, E.Yoshino, K.Ono, T.Kobayashi, T.Ido and Y.Mishima, A basic concept for PET-BNCT system, in: Cancer Neutron Capture Therapy, Y.Mishima,ed. pp. 691–696, Plenum, New York, 1996.

    Google Scholar 

  9. S.Ueda, YImahori, N.Ibayashi, Y.Ohmori, K.Ono, T.Kobayashi and K.Akuta. The basic studies for boron neutron capture therapy(BNCT) of brain tumor using boronophenylalanine. KURRI Prog. Rep.,Osaka, 1992, 304–305.

    Google Scholar 

  10. J.A.Coderre, D.D.Joel, P.L.Micca, M.M.Nawrocky and D.N.Slatkin, Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiation Res. 129, 290–296, 1992.

    Article  PubMed  CAS  Google Scholar 

  11. J.A.Coderre, J.D.Glass, R.G.Fairchild, P.L.Micca, l.Fand and D.D.Joel, Affinity of the melanin precursor analog p-boronophenylalanine for tumors other than melanoma. Cancer Res. 50, 138–141, 1990.

    PubMed  CAS  Google Scholar 

  12. D.Gabel, Safety and efficacy in boron neutron capture therapy, in: Boron Neutron Capture Therapy, toward Clinical Trials of Glioma Treatment, D.Gabel and R.Moss ed., Plenum, New York, 1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ueda, S. et al. (1996). Positron Emission Tomography and Boron Neutron Capture Therapy System to the Patient with Malignant Brain Tumor. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_116

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9567-7_116

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9569-1

  • Online ISBN: 978-1-4757-9567-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics